Literature DB >> 24531695

A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions.

Nataporn Chaipichit1, Janet Krska, Thongchai Pratipanawatr, Verawan Uchaipichat, Narumol Jarernsiripornkul.   

Abstract

PURPOSE: To explore how Thai patients assess symptoms as adverse drug reactions (ADRs).
METHODS: Out-patients at two hospitals in Thailand previously reporting suspected ADRs to statins were purposively selected to cover factors relevant to the accuracy of ADR reports. Semi-structured interviews explored the mechanisms participants used to work out whether their symptoms were related to their statin. All interviews were audio-recorded, transcribed and independently thematically analyzed by two researchers.
RESULTS: One hundred interviews were suitable for analysis; 52 were male, age range was 36 to 77 years (mean ± S.D.: 59.83 ± 9.14) and most (92) were taking other medicines in addition to statins. Patient assessment of symptoms as ADRs fell into two major themes: medicine-related factors and external factors. Timing relationships were mentioned most frequently (74), followed by information received (55), seeing similar symptoms in others (7) and diagnosis through blood tests (4). Use of multiple medicines, consideration of the medicine versus diseases, symptoms occurring with more than one medicine or relieved through treatment reduced confidence in ADR attribution. Many participants proposed alternative explanations for symptoms, including old age. Lack of information and knowledge were obstacles to the assessment process.
CONCLUSIONS: Patients assessed possible ADRs most often by considering timing relationships. While they also used medicine information, Thai patients received inadequate information to help them assess their symptoms. Patients expressed uncertainty and difficulties in deciding attribution when concomitant medicines and diseases were involved. The findings could support the development of a patient-friendly systematic tool for identifying and assessing possible ADRs.

Entities:  

Mesh:

Year:  2014        PMID: 24531695     DOI: 10.1007/s00228-014-1653-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  30 in total

1.  [Direct reporting of side effects by the patient: favourable experience in the first year].

Authors:  A C van Grootheest; J L M Passier; E P van Puijenbroek
Journal:  Ned Tijdschr Geneeskd       Date:  2005-03-05

2.  Patient reporting of suspected adverse drug reactions to antiepileptic drugs: factors affecting attribution accuracy.

Authors:  Narumol Jarernsiripornkul; Piyanida Senacom; Verawan Uchaipichat; Nataporn Chaipichit; Janet Krska
Journal:  Epilepsy Behav       Date:  2012-04-18       Impact factor: 2.937

3.  Do older hospital patients recognize adverse drug reactions?

Authors:  C K Mannesse; F H Derkx; M A de Ridder; A J Man in 't Veld; T J van der Cammen
Journal:  Age Ageing       Date:  2000-01       Impact factor: 10.668

4.  Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs.

Authors:  N Jarernsiripornkul; W Kakaew; W Loalukkana; J Krska
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-03       Impact factor: 2.890

5.  Patient self-reporting of potential adverse drug reactions to non-steroidal anti-inflammatory drugs in Thailand.

Authors:  Narumol Jarernsiripornkul; Sudarat Chaisrisawadsuk; Aporanee Chaiyakum; Janet Krska
Journal:  Pharm World Sci       Date:  2009-07-04

6.  Statin-related adverse events: a meta-analysis.

Authors:  Matthew A Silva; Anna C Swanson; Pritesh J Gandhi; Gary R Tataronis
Journal:  Clin Ther       Date:  2006-01       Impact factor: 3.393

7.  Adverse drug reaction reporting by patients in the Netherlands: three years of experience.

Authors:  Joyce de Langen; Florence van Hunsel; Anneke Passier; Lolkje de Jong-van den Berg; Kees van Grootheest
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

8.  Patients as a direct source of information on adverse drug reactions.

Authors:  A S Mitchell; D A Henry; R Sanson-Fisher; D L O'Connell
Journal:  BMJ       Date:  1988-10-08

9.  Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire.

Authors:  Sieta T de Vries; Peter G M Mol; Dick de Zeeuw; Flora M Haaijer-Ruskamp; Petra Denig
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

10.  Adherence to lipid-lowering treatment: the patient perspective.

Authors:  Manuela Casula; Elena Tragni; Alberico Luigi Catapano
Journal:  Patient Prefer Adherence       Date:  2012-11-08       Impact factor: 2.711

View more
  16 in total

1.  Resident and nurse reports of potential adverse drug reactions.

Authors:  Tinne Dilles; Bart Van Rompaey; Peter Van Bogaert; Monique M Elseviers
Journal:  Eur J Clin Pharmacol       Date:  2015-04-24       Impact factor: 2.953

2.  Patient beliefs and attitudes to taking statins: systematic review of qualitative studies.

Authors:  Angela Ju; Camilla S Hanson; Emily Banks; Rosemary Korda; Jonathan C Craig; Tim Usherwood; Peter MacDonald; Allison Tong
Journal:  Br J Gen Pract       Date:  2018-06       Impact factor: 5.386

Review 3.  The value of patient reporting to the pharmacovigilance system: a systematic review.

Authors:  Pedro Inácio; Afonso Cavaco; Marja Airaksinen
Journal:  Br J Clin Pharmacol       Date:  2016-10-12       Impact factor: 4.335

4.  Public confidence in ADR identification and their views on ADRreporting: mixed methods study.

Authors:  Narumol Jarernsiripornkul; Arunrot Patsuree; Janet Krska
Journal:  Eur J Clin Pharmacol       Date:  2016-11-11       Impact factor: 2.953

5.  Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand.

Authors:  Joanne Barnes; Rachael Butler
Journal:  Drug Saf       Date:  2020-11       Impact factor: 5.606

6.  Hospital pharmacists' roles and attitudes in providing information on the safety of non-steroidal anti-inflammatory drugs in Thailand.

Authors:  Pacharaporn Phueanpinit; Narumol Jarernsiripornkul; Juraporn Pongwecharak; Janet Krska
Journal:  Int J Clin Pharm       Date:  2014-10-07

7.  Gender differences in statin prescription rates, adequacy of dosing, and association of statin therapy with outcome after heart failure hospitalization: a retrospective analysis in a community setting.

Authors:  Piercarlo Ballo; Daniela Balzi; Alessandro Barchielli; Lucia Turco; Flavia Franconi; Alfredo Zuppiroli
Journal:  Eur J Clin Pharmacol       Date:  2015-11-19       Impact factor: 2.953

8.  Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study.

Authors:  Sieta T de Vries; Flora M Haaijer-Ruskamp; Dick de Zeeuw; Petra Denig
Journal:  Health Qual Life Outcomes       Date:  2014-08-13       Impact factor: 3.186

9.  Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study.

Authors:  Sieta T de Vries; Lisa Wong; Alastair Sutcliffe; François Houÿez; Carmen Lasheras Ruiz; Peter G M Mol
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

10.  Evaluation of Potentially Drug-Related Patient-Reported Common Symptoms Assessed During Clinical Medication Reviews: A Cross-Sectional Observational Study.

Authors:  Tim W A Schoenmakers; Martina Teichert; Michel Wensing; Peter A G M de Smet
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.